Authors reported that the removal of the tumor produced few changes in the cellular immune response at 1 month post-nephrectomy, for example the level of circulating BTLA(B and T lymphocyte attenuator)-expressing CD8+ T cells decreased significantly, suggesting a reversal of T-cell exhaustion and dysfunction (15). The gene discussed is CD8A; the disease is neoplasm.